Company Overview
Snapshot
Founded in February 2013 by Danny Farin, Saturix operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on developing its core technology.
Business overview
Saturix is a Health Tech & Life Sciences company developing a solution for laparoscopic suturing. Its core product, PerSew, aims to dramatically simplify and shorten surgical procedures, enhancing surgeon performance and increasing patient safety. The company initially targets bariatric surgeries and operates within the medical devices, surgical instruments, and medical technologies sectors, serving hospitals and surgeons.
Log in to access full profile ›Company Intelligence Q&A
- What is Saturix's primary focus?
- Saturix focuses on developing advanced laparoscopic suturing devices to improve surgical efficiency and patient safety, initially targeting bariatric surgeries.
- When was Saturix founded?
- Saturix was founded in February 2013.
- Who is a co-founder of Saturix?
- Danny Farin is a co-founder of Saturix.
- What is the current product stage of Saturix?
- Saturix's product, PerSew, is currently in the R&D stage, as of 2018, with the goal of simplifying and shortening laparoscopic procedures.
- What markets does Saturix target?
- Saturix targets the healthcare market, specifically providers such as hospitals and surgeons, with a focus on gastroenterology and surgical procedures.